TRIMETAZIDINE: 431 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
431
Total FAERS Reports
33 (7.7%)
Deaths Reported
264
Hospitalizations
431
As Primary/Secondary Suspect
13
Life-Threatening
11
Disabilities
Active Ingredient: TRIMETAZIDINE DIHYDROCHLORIDE ·
First Report: 2000 · Latest Report: 20250310
What Are the Most Common TRIMETAZIDINE Side Effects?
#1 Most Reported
Cardiac failure
73 reports (16.9%)
#2 Most Reported
Rales
63 reports (14.6%)
#3 Most Reported
Ejection fraction decreased
62 reports (14.4%)
All TRIMETAZIDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Cardiac failure | 73 | 16.9% | 2 | 69 |
| Rales | 63 | 14.6% | 0 | 63 |
| Ejection fraction decreased | 62 | 14.4% | 0 | 62 |
| Dyspnoea | 59 | 13.7% | 0 | 52 |
| Fatigue | 59 | 13.7% | 0 | 51 |
| Diastolic dysfunction | 52 | 12.1% | 0 | 43 |
| Oedema peripheral | 49 | 11.4% | 0 | 46 |
| Tricuspid valve incompetence | 49 | 11.4% | 0 | 49 |
| Mitral valve incompetence | 45 | 10.4% | 0 | 44 |
| Dyspnoea at rest | 44 | 10.2% | 0 | 44 |
| Left ventricular dysfunction | 43 | 10.0% | 0 | 42 |
| Hypertension | 42 | 9.7% | 2 | 33 |
| Hypotension | 42 | 9.7% | 0 | 34 |
| Cardiomegaly | 40 | 9.3% | 0 | 39 |
| Atrial fibrillation | 37 | 8.6% | 0 | 31 |
| Acute myocardial infarction | 36 | 8.4% | 0 | 36 |
| Left ventricular hypertrophy | 36 | 8.4% | 0 | 27 |
| Stenosis | 36 | 8.4% | 0 | 36 |
| Asthenia | 35 | 8.1% | 0 | 31 |
| Bundle branch block left | 34 | 7.9% | 0 | 34 |
Who Reports TRIMETAZIDINE Side Effects? Age & Gender Data
Gender: 32.3% female, 67.7% male. Average age: 68.4 years. Most reports from: PL. View detailed demographics →
Is TRIMETAZIDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 6 | 0 | 6 |
| 2005 | 8 | 0 | 8 |
| 2007 | 1 | 0 | 1 |
| 2008 | 6 | 0 | 6 |
| 2009 | 13 | 9 | 4 |
| 2012 | 10 | 0 | 9 |
| 2013 | 6 | 0 | 4 |
| 2014 | 9 | 0 | 3 |
| 2015 | 21 | 1 | 14 |
| 2016 | 30 | 8 | 17 |
| 2017 | 28 | 0 | 25 |
| 2018 | 23 | 2 | 10 |
| 2019 | 49 | 0 | 37 |
| 2020 | 18 | 0 | 12 |
| 2021 | 25 | 0 | 16 |
| 2022 | 9 | 2 | 6 |
| 2023 | 8 | 0 | 3 |
| 2024 | 6 | 0 | 0 |
| 2025 | 2 | 0 | 0 |
What Is TRIMETAZIDINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 266 |
| Hypertension | 20 |
| Angina pectoris | 17 |
| Coronary artery disease | 11 |
| Cardiac disorder | 7 |
| Vertigo | 7 |
| Myocardial ischaemia | 6 |
| Myocardial infarction | 5 |
TRIMETAZIDINE vs Alternatives: Which Is Safer?
TRIMETAZIDINE vs TRIMETHOBENZAMIDE
TRIMETAZIDINE vs TRIMETHOPRIM
TRIMETAZIDINE vs TRIMIPRAMINE
TRIMETAZIDINE vs TRIPROLIDINE
TRIMETAZIDINE vs TRIPTORELIN
TRIMETAZIDINE vs TRISODIUM
TRIMETAZIDINE vs TROFINETIDE
TRIMETAZIDINE vs TROFOSFAMIDE
TRIMETAZIDINE vs TROPATEPINE
TRIMETAZIDINE vs TROPICAMIDE
Official FDA Label for TRIMETAZIDINE
Official prescribing information from the FDA-approved drug label.